# Dummy Output Templates

## Overview
This directory contains example output files that demonstrate the format and structure of results generated by the Clinical NGS Pipeline. These templates are useful for:
- Understanding output file formats
- Testing downstream analysis workflows
- Training and demonstration purposes
- Quality control verification

## Directory Structure

```
dummy_outputs/
├── README.md                          # This file
├── fastqc/                            # FastQC quality control metrics
│   └── SAMPLE001_fastqc.json
├── alignment/                         # BWA-MEM alignment statistics
│   └── SAMPLE001_alignment_stats.json
├── coverage/                          # Coverage analysis results
│   └── SAMPLE001_coverage.json
├── variants/                          # Variant calling outputs
│   ├── germline/                      # Germline variant files
│   │   ├── SAMPLE001.germline.filtered.vcf.gz
│   │   └── SAMPLE001.annotated.tsv
│   └── somatic/                       # Somatic variant files
│       ├── PATIENT001.somatic.filtered.vcf.gz
│       └── PATIENT001.annotated.tsv
├── cnv/                               # Copy number variation analysis
│   └── SAMPLE001_cnv_calls.json
├── qc/                                # Quality control reports
│   └── SAMPLE001_multiqc_report.html
└── reports/                           # Clinical interpretation reports
    ├── SAMPLE001_clinical_report.html          # Germline report
    └── PATIENT001_somatic_clinical_report.html # Somatic report
```

## File Descriptions

### 1. FastQC Output (`fastqc/`)
**File:** `SAMPLE001_fastqc.json`
- Raw sequencing quality metrics
- Read quality scores, GC content, sequence duplication
- Per-base quality distribution

### 2. Alignment Statistics (`alignment/`)
**File:** `SAMPLE001_alignment_stats.json`
- BWA-MEM alignment metrics
- Mapping rate, properly paired reads
- Insert size distribution
- On-target rate for targeted sequencing

### 3. Coverage Analysis (`coverage/`)
**File:** `SAMPLE001_coverage.json`
- Per-gene and per-exon coverage statistics
- Uniformity metrics
- Regions with insufficient coverage
- Critical for clinical interpretation

### 4. Variant Calls (`variants/`)

#### Germline Analysis
**Files:**
- `SAMPLE001.germline.filtered.vcf.gz` - Standard VCF format with filtered variants
- `SAMPLE001.annotated.tsv` - Human-readable TSV with annotations

**Contains:**
- Constitutional variants (SNVs, INDELs)
- Population allele frequencies (gnomAD, 1000 Genomes)
- Clinical significance (ClinVar)
- Gene-disease associations

#### Somatic Analysis
**Files:**
- `PATIENT001.somatic.filtered.vcf.gz` - Tumor-specific variants
- `PATIENT001.annotated.tsv` - Annotated somatic variants

**Contains:**
- Somatic SNVs and INDELs
- Variant allele frequency (VAF)
- Therapeutic actionability (OncoKB, CIViC)
- COSMIC database annotations
- Resistance mutations

### 5. Copy Number Variants (`cnv/`)
**File:** `SAMPLE001_cnv_calls.json`
- Focal amplifications and deletions
- Whole-gene copy number changes
- Clinical interpretation for cancer-associated genes
- Therapeutic implications (e.g., ERBB2/HER2 amplification)

### 6. Quality Control Reports (`qc/`)
**File:** `SAMPLE001_multiqc_report.html`
- Comprehensive QC dashboard
- Aggregates all quality metrics
- Interactive HTML report
- Pass/Warning/Fail flags for each metric

### 7. Clinical Reports (`reports/`)

#### Germline Clinical Report
**File:** `SAMPLE001_clinical_report.html`
- Patient-facing clinical interpretation
- Pathogenic and likely pathogenic variants
- Variants of uncertain significance (VUS)
- Pharmacogenomic implications
- Clinical recommendations
- Genetic counseling notes

**Key Sections:**
- Quality metrics summary
- Clinically significant variants (ACMG classification)
- Pharmacogenomics (drug metabolism)
- Technical limitations
- Recommendations for follow-up

#### Somatic Clinical Report
**File:** `PATIENT001_somatic_clinical_report.html`
- Precision oncology report
- FDA-approved targeted therapies
- Clinical trial matching
- Tumor mutational burden (TMB)
- Microsatellite instability (MSI)
- Copy number alterations

**Key Sections:**
- Tier 1A: FDA-approved therapies (e.g., EGFR L858R → Osimertinib)
- Tier 1B: Clinical guidelines-supported therapies
- Tier 2: Investigational therapies
- Resistance mutations
- TMB and immunotherapy eligibility

## Clinical Interpretation Guidelines

### Germline Variants
1. **Pathogenic/Likely Pathogenic:** High confidence disease-causing
   - Example: BRCA1 c.5266dupC → Hereditary breast/ovarian cancer
   
2. **VUS (Variants of Uncertain Significance):** Insufficient evidence
   - Recommend periodic re-classification
   - May become reclassified as evidence accumulates

3. **Benign/Likely Benign:** No clinical action required

### Somatic Variants

#### Tiering System (AMP/ASCO/CAP Guidelines)
- **Tier 1A:** FDA-approved biomarkers with clinical evidence
- **Tier 1B:** Professional guideline-supported biomarkers
- **Tier 2:** Emerging evidence, investigational
- **Tier 3:** Uncertain significance in cancer context

#### Actionability Examples:
- **EGFR L858R** (NSCLC) → Osimertinib (FDA-approved)
- **BRAF V600E** (Melanoma) → Dabrafenib + Trametinib
- **PIK3CA mutations** (HR+ Breast) → Alpelisib
- **NTRK fusions** (Tumor-agnostic) → Larotrectinib

## Quality Thresholds

### Minimum Acceptable Metrics (Clinical-Grade)
| Metric | Germline | Somatic (Tumor) | Somatic (Normal) |
|--------|----------|-----------------|------------------|
| Mean Coverage | ≥100x | ≥250x | ≥100x |
| % Targets at 50x | ≥95% | ≥98% | ≥95% |
| On-Target Rate | ≥80% | ≥85% | ≥80% |
| Duplicate Rate | <30% | <25% | <30% |
| Alignment Rate | ≥95% | ≥95% | ≥95% |

## Using These Templates

### For Testing
```bash
# Copy dummy outputs to test downstream tools
cp dummy_outputs/variants/germline/*.vcf.gz /path/to/test/
cp dummy_outputs/reports/*.html /path/to/visualization/
```

### For Training
- Use HTML reports for teaching clinical interpretation
- Compare actual pipeline outputs against these templates
- Verify annotation completeness

### For Quality Control
- Compare your pipeline outputs to these reference formats
- Ensure all required fields are populated
- Validate HTML report rendering

## Important Notes

⚠️ **These are synthetic example files for demonstration only**
- Do not use for actual clinical decision-making
- Variant calls and annotations are fabricated
- Quality metrics are representative, not real data
- Patient identifiers are fictional

✅ **Production Use:**
- Always validate outputs against known reference samples
- Implement orthogonal validation for clinical variants
- Follow CLIA/CAP guidelines for clinical reporting
- Maintain chain of custody for patient samples

## Updating Templates

When adding new output types or modifying formats:
1. Create representative dummy files
2. Update this README
3. Document in main pipeline README
4. Add to integration tests

## Contact

For questions about output formats or clinical interpretation:
- **Pipeline Maintainer:** Prabir Kumar
- **Email:** prabir@example.org
- **Documentation:** See main README.md and USER_MANUAL.md

---

**Last Updated:** February 1, 2026  
**Pipeline Version:** 2.0  
**Maintained by:** Prabir Kumar
